You are here


Frédéric Chevallier

Frédéric Chevallier


Frédéric is an IP litigator with particular experience in the Life sciences and TMT fields.



Frédéric is a partner in the firm's Intellectual Property practice in Paris specialising in cross-border litigation, including the related regulatory aspects in the pharmaceutical field. He has developed particularly strong expertise in the life sciences and TMT fields, being involved in a number of major and high value patent cases for leading innovator pharmaceutical companies and leading TMT actors.

Frédéric’s practice notably focuses on representing pharmaceutical innovators and high-tech companies in cross-border patent litigation involving numerous jurisdictions. He also has extensive experience in both advising and acting in Intellectual Property disputes in France, including for trademark and copyright related advice and disputes.  

Frédéric’s experience includes advising:

  • Major international pharmaceutical companies on the enforcement of patent and SPC rights on antibodies, small molecules, and second medical use claims, including in preliminary injunction and provisional damages proceedings
  • International companies on the remuneration of their employee inventors and assignment of inventions
  • Major oil companies on the enforcement of their Intellectual Property rights
  • Major French and foreign smartphone and networks providers on the pan-European enforcement of their Intellectual Property rights, including their copyright, models and standard essential patents (FRAND).


Prior to joining Herbert Smith Freehills, Frédéric was counsel in the IP department of an international law firm in Paris.

Related content

17th February 2023
The Unified Patent Court and unitary patent are now set to become a reality on...
17th February 2023
The UPC website provides brief information about Court Fees here and the Administrative Committee of...
17th February 2023
The UPC will have a Court of First Instance (divided into local, regional and central...
17th February 2023
On July 2022 the UPC Rules of Procedure (the RoP) were announced as approved with...